Search research articles
Contact Us
Filters
Showing results (111-120 of 135) with videos related to
Page
of 14
Sort By:
Clinical Lung Cancer
|
January 14, 2015
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial
Domenico Galetta, Saverio Cinieri, Salvatore Pisconti, et al.
Journal of Global Health
|
November 14, 2025
Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees: a Delphi-based study
Domenico Pascucci, Aina Nicolàs, Abdelrahman Taha, et al.
Future Oncology (London, England)
|
May 7, 2014
Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study
Laura Orlando, Francesco Giotta, Vito Lorusso, et al.
Frontiers in Medicine
|
August 11, 2023
Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones
Alicia Rovó, Mathilde Gavillet, Beatrice Drexler, et al.
Stroke
|
May 7, 2011
Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis
Simon Jung, Marie-Luise Mono, Urs Fischer, et al.
Breast (Edinburgh, Scotland)
|
June 17, 2020
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM)
Laura Orlando, Vito Lorusso, Francesco Giotta, et al.
Journal of Thrombosis and Thrombolysis
|
August 18, 2020
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis
Chiara Kessler, Hans Stricker, Daniela Demundo, et al.
Breast (Edinburgh, Scotland)
|
April 14, 2024
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial
Laura Orlando, Evaristo Maiello, Michele Orditura, et al.
Research and Practice in Thrombosis and Haemostasis
|
September 10, 2024
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial
Riccardo M Fumagalli, Davide Voci, Behnood Bikdeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2010
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study
Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 135) with videos related to
Sort By:
Page
of 14
Clinical Lung Cancer
|
January 14, 2015
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial
Domenico Galetta, Saverio Cinieri, Salvatore Pisconti, et al.
Journal of Global Health
|
November 14, 2025
Monitoring and evaluation of community interventions for viral hepatitis among migrants and refugees: a Delphi-based study
Domenico Pascucci, Aina Nicolàs, Abdelrahman Taha, et al.
Future Oncology (London, England)
|
May 7, 2014
Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study
Laura Orlando, Francesco Giotta, Vito Lorusso, et al.
Frontiers in Medicine
|
August 11, 2023
Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones
Alicia Rovó, Mathilde Gavillet, Beatrice Drexler, et al.
Stroke
|
May 7, 2011
Three-month and long-term outcomes and their predictors in acute basilar artery occlusion treated with intra-arterial thrombolysis
Simon Jung, Marie-Luise Mono, Urs Fischer, et al.
Breast (Edinburgh, Scotland)
|
June 17, 2020
Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM)
Laura Orlando, Vito Lorusso, Francesco Giotta, et al.
Journal of Thrombosis and Thrombolysis
|
August 18, 2020
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis
Chiara Kessler, Hans Stricker, Daniela Demundo, et al.
Breast (Edinburgh, Scotland)
|
April 14, 2024
Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial
Laura Orlando, Evaristo Maiello, Michele Orditura, et al.
Research and Practice in Thrombosis and Haemostasis
|
September 10, 2024
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial
Riccardo M Fumagalli, Davide Voci, Behnood Bikdeli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2010
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study
Giuseppe Colucci, Roberto Labianca, Francesco Di Costanzo, et al.
Page
of 14